https://www.selleckchem.com/pr....oducts/Bosutinib.htm
Background This study determines how much cytoreduction for small bowel neuroendocrine tumors with peritoneal carcinomatosis and liver metastases can be achieved and the corresponding survival benefits of different levels of clearance. Methods Records of patients with small bowel neuroendocrine tumors with peritoneal carcinomatosis were reviewed and scored using the Lyon Stage system. Kaplan-Meier survival was calculated and compared by log-rank analysis. Results Among 323 patients with small bowel neuroendocrine tumors identified, 98
Aimer
Commentaire
Partagez
